Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Research Article

Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

	Abstract	Full	Pdf
Dec 2019	3	3	0
Jan 2020	9	9	3
Feb 2020	18	18	4
Mar 2020	23	23	3
Apr 2020	14	14	4
May 2020	36	36	1
Jun 2020	30	30	3
Jul 2020	31	31	7
Aug 2020	18	18	1
Sep 2020	25	25	2
Oct 2020	34	34	4
Nov 2020	25	24	7
Dec 2020	23	23	9
Jan 2021	26	26	8
Feb 2021	23	23	2
Mar 2021	21	21	3
Apr 2021	18	18	6
May 2021	32	32	4
Jun 2021	15	15	4
Jul 2021	20	20	6
Aug 2021	10	10	2
Sep 2021	19	19	7
Oct 2021	23	23	9
Nov 2021	14	14	1
Dec 2021	30	30	3
Jan 2022	36	37	9
Feb 2022	17	17	5
Mar 2022	16	16	1
Apr 2022	25	26	5
May 2022	34	34	5
Jun 2022	25	26	2
Jul 2022	34	35	8
Aug 2022	38	40	24
Sep 2022	33	33	2
Oct 2022	27	27	6
Nov 2022	25	27	15
Dec 2022	29	29	5
Jan 2023	39	39	9
Feb 2023	47	47	2
Mar 2023	34	35	4
Apr 2023	22	23	7
May 2023	25	25	4
Jun 2023	21	21	3
Jul 2023	20	20	4
Aug 2023	25	25	8
Sep 2023	28	28	2
Oct 2023	24	24	5
Nov 2023	68	72	6
Dec 2023	100	100	10
Jan 2024	47	50	7
Feb 2024	36	37	7
Mar 2024	35	35	7
Total	1450	1467	275